Tue, 24th Sep 2019 12:40
(Alliance News) - Clinical stage biotechnology firm ValiRx PLC said on Tuesday it has received an HMRC research & development tax credit of GBP423,000.
The company said it continues to "carefully manage" its working capital position.
Shares in ValiRx were up 7.6% at 0.1667 pence in London on Tuesday.
By Lucy Heming; lucyheming@alliancenews.com
Copyright 2019 Alliance News Limited. All Rights Reserved.
(Alliance News) - Stock prices in London closed higher on Monday, with investors optimistic that interest rate cuts might be around the corner.
(Alliance News) - ValiRx PLC on Monday noted that the peptide nanoparticle formation Cytolytix received a Knowledge Transfer Voucher grant in conjunct...
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
ValiRx (VAL)